Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Histidine and Carbidopa for Fatigue in Multiple Sclerosis
NCT03266965Phase 1Completed
- Sponsor
- University of Miami
- Start
- Mar 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of l-histidine and carbidopa in multiple sclerosis (MS), sponsored by University of Miami. Primary endpoint: Number of adverse events experienced by participants at 30 days. Started Mar 2018; status: completed.
02
Drugs
l-histidinecarbidopa
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03266965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266965.